These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
821 related items for PubMed ID: 2971155
1. Mechanisms for the anticoagulant effect of heparin and related polysaccharides. Ofosu FA. Nouv Rev Fr Hematol (1978); 1988; 30(3):155-60. PubMed ID: 2971155 [Abstract] [Full Text] [Related]
2. Mechanisms for inhibition of the generation of thrombin activity by sulfated polysaccharides. Ofosu FA, Modi GJ, Hirsh J, Buchanan MR, Blajchman MA. Ann N Y Acad Sci; 1986; 485():41-55. PubMed ID: 2436525 [Abstract] [Full Text] [Related]
3. Plasma anticoagulant mechanisms of heparin, heparan sulfate, and dermatan sulfate. Ofosu FA, Buchanan MR, Anvari N, Smith LM, Blajchman MA. Ann N Y Acad Sci; 1989; 556():123-31. PubMed ID: 2525356 [Abstract] [Full Text] [Related]
4. Heparan sulfate and dermatan sulfate inhibit the generation of thrombin activity in plasma by complementary pathways. Ofosu FA, Modi GJ, Smith LM, Cerskus AL, Hirsh J, Blajchman MA. Blood; 1984 Sep; 64(3):742-7. PubMed ID: 6235872 [Abstract] [Full Text] [Related]
5. Heparin cofactor II and other endogenous factors in the mediation of the antithrombotic and anticoagulant effects of heparin and dermatan sulfate. Ofosu FA, Fernandez F, Gauthier D, Buchanan MR. Semin Thromb Hemost; 1985 Apr; 11(2):133-7. PubMed ID: 3898370 [No Abstract] [Full Text] [Related]
6. Dermatan sulfate is a more potent inhibitor of clot-bound thrombin than unfractionated and low molecular weight heparins. Bendayan P, Boccalon H, Dupouy D, Boneu B. Thromb Haemost; 1994 May; 71(5):576-80. PubMed ID: 8091383 [Abstract] [Full Text] [Related]
7. Increased sulphation improves the anticoagulant activities of heparan sulphate and dermatan sulphate. Ofosu FA, Modi GJ, Blajchman MA, Buchanan MR, Johnson EA. Biochem J; 1987 Dec 15; 248(3):889-96. PubMed ID: 2963622 [Abstract] [Full Text] [Related]
8. Fibrin moderates the catalytic action of heparin but not that of dermatan sulfate on thrombin inhibition in human plasma. Okwusidi JI, Anvari N, Kulczycky M, Blajchman MA, Buchanan MR, Ofosu FA. J Lab Clin Med; 1991 May 15; 117(5):359-64. PubMed ID: 2019790 [Abstract] [Full Text] [Related]
20. Effects on platelets and on the clotting system of four glycosaminoglycans extracted from hog mucosa and one extracted from aortic intima of the calf. Cella G, Scattolo N, Luzzatto G, Stevanato F, Vio C, Girolami A. J Med; 1986 Sep 15; 17(5-6):331-46. PubMed ID: 2953835 [Abstract] [Full Text] [Related] Page: [Next] [New Search]